Top 10 Companies Likely to Transact: August 10 - 14, 2026

Data sourced from Joe, the private fund performance platform powered by Dakota. Learn More | Request Access

Tracking when private companies are nearing a sale, recap, or financing event has always been a guessing game. With thousands of sponsor-backed firms spread across sectors and geographies, most deal teams are forced to react after the market moves.

Investors, bankers, and service providers struggle to know which private companies are gearing up for a transaction or capital raise. Signals are scattered, opaque, and nearly impossible to track across thousands of PE- and VC-backed businesses.

Joe, powered by Daktoa centralizes those signals (holding periods, funding rounds, platform acquisition dates, ownership changes, and exit timing patterns) into one predictive transaction-readiness tool. Instead of waiting for headlines, users can see which companies are showing the strongest likelihood of pursuing a sale, recapitalization, or new financing before the market knows.

Below is our weekly roundup of ten PE- or VC-backed companies that, based on their hold period, financing stage, and last transaction date, appear to be credible candidates for a sale or next-round raise.

Nothing is guaranteed, but these companies fall squarely within the timing windows where sponsors typically look to generate liquidity or secure additional capital.

Top 10 Companies Likely to Transact: August 3 - 7

1. Wattch

Wattch is a software development company specializing in scalable energy data analytics platforms for the renewable energy industry. Their solutions provide monitoring, intelligence, and control for renewable energy systems, including solar, storage, EV charging, load monitoring, and ESG reporting.

• Sector: Information Technology
• Last known transaction date: Seed Venture, $6M, August 2025
• Why timing suggests a near-term transaction: A $6M seed round in August 2025 provides roughly 12–18 months of runway for an energy monitoring or analytics IT company, where engineering talent, product development, and early enterprise customer acquisition drive steady burn — placing Wattch in the active fundraising window for a Series A by late 2026 as it looks to demonstrate platform adoption, early revenue traction, and the energy intelligence metrics that institutional Series A investors require.

2. OLarry, Inc.

OLarry, Inc. is a financial services firm specializing in comprehensive tax planning and compliance solutions for individuals, families, and businesses. Their services include U.S. tax compliance, foreign tax reporting, tax consulting, and emerging wealth management, aiming to make financial strategies transparent and accessible.

• Sector: Fintech
• Last known transaction date: Series A Venture, $10M, August 2025
• Why timing suggests a near-term transaction: A $10M Series A in August 2025 provides roughly 18 months of runway for a fintech company, where regulatory compliance, technology infrastructure, and customer acquisition costs drive steady capital consumption — placing OLarry in the active fundraising window for a Series B by late 2026 as it looks to demonstrate revenue scale, user growth, and the unit economics that growth-stage financial services investors require.

3. EON Space Labs

Eon Space Labs is an Indian aerospace company specializing in the design, development, and manufacturing of advanced optical payloads and systems for satellites, drones, and ground platforms. Their solutions cater to applications in surveillance, agriculture, natural resources, and disaster management, aiming to democratize Earth observation through cutting-edge technology.

• Sector: Industrials
• Last known transaction date: Pre-Series A Venture, $1.2M, August 2025
• Why timing suggests a near-term transaction: A $1.2M Pre-Series A in August 2025 is an exceptionally lean raise for a space industrials company, providing just 12 months or less of runway given satellite development, launch costs, and regulatory approvals — suggesting EON Space Labs is very likely already in active fundraising conversations for a follow-on round and could be seeking to close additional capital by mid-to-late 2026 before runway constraints become critical.

4. DISA Technologies Inc.

DISA Technologies Inc. specializes in High-Pressure Slurry Ablation (HPSA), a patented technology designed to enhance mineral recovery by upgrading critical minerals from mined ore and legacy waste. Their services cater to both the mining and remediation sectors, aiming to improve mineral processing grades, reduce site contamination, and promote sustainable practices.

• Sector: Materials
• Last known funding round: Series A2 Venture, $30M, August 2025
• Why timing suggests a near-term transaction: A $30M Series A2 in August 2025 provides roughly 18–24 months of runway for a materials technology company, where R&D, manufacturing scale-up, and enterprise customer validation drive elevated capital consumption — placing DISA Technologies in the active fundraising window for a Series B by late 2026 to early 2027 as it looks to demonstrate commercial production milestones, customer adoption, and the materials performance metrics that growth-stage deep tech investors require.

5. Elion

Elion is a digital health software marketplace founded in 2022, designed to connect healthcare providers with various software and service vendors through its online platform. The company offers features like comprehensive vendor listings, detailed product evaluations, and educational resources, enabling healthcare providers to research, compare, and select the right technology to improve their operations and patient care.

• Sector: Health Care
• Last known funding round: Seed Venture, $9.3M, August 2025
• Why timing suggests a near-term transaction: A $9.3M seed round in August 2025 provides roughly 12–18 months of runway for a healthcare company, where regulatory, clinical, and product development costs are elevated relative to other sectors — placing Elion in the active fundraising window for a Series A by late 2026 as early proof-of-concept milestones and initial clinical validation from the seed period provide the proof points needed to attract institutional capital.

Knowing which companies are close to a transaction is half the picture. Joe, powered by Dakota, shows you how the funds holding them have actually performed. Request access.

6. Better Nature

Better Nature is a UK-based company specializing in plant-based protein products, particularly tempeh, to provide nutritious options for vegan diets. Their offerings include organic tempeh, smoky tempeh, and Mediterranean tempeh pieces, all designed to deliver high protein content and gut-friendly benefits.

• Sector: Consumer Staples
• Last known funding round: Seed Venture, $1.5M, August 2025
• Why timing suggests a near-term transaction: A $1.5M seed round in August 2025 represents a very lean capital base for a consumer staples brand, providing just 12 months or less of runway given product development, manufacturing, and retail distribution buildout costs — suggesting Better Nature is very likely already in active fundraising conversations for a Series A and could be seeking to close a round by mid-2026 before runway constraints become critical.

7. Bonus Homes

Bonus Homes is a real estate technology and investment company developing alternative homeownership solutions. Its Home Appreciation Partnership (HAP) model enables homeowners to access their home equity while retaining a share of future appreciation, providing greater financial flexibility and mobility while preserving long-term wealth-building potential.

• Sector: Real Estate
• Last known transaction date: Seed Venture, $65.5M, August 2025
• Why timing suggests a near-term transaction: Bonus Homes’ $65.5M seed round announced in August 2025 places the company approximately 12–18 months removed from a significant initial financing by mid to late 2026, aligning with the typical window when well-capitalized seed-stage companies begin preparing for their next growth round. Given the size of the raise and capital requirements associated with scaling real estate operations, the company is likely to evaluate follow-on growth capital, strategic real estate partnerships, or acquisition interest as its portfolio and market presence expand.

8. Develop Health

Develop Health is an AI-powered healthcare technology company that automates the prior authorization process for healthcare providers. Its platform completes authorization requests and recommends care plan adjustments to improve approval rates, reduce administrative work, and accelerate patient access to treatment.

• Sector: Health Care
• Last known funding round: Series A Venture, $14.3M, August 2025
• Why timing suggests a near-term transaction: Develop Health’s $14.3M Series A announced in August 2025 places the company roughly 12–18 months removed from its most recent financing by mid to late 2026, aligning with the typical timing for Series A healthcare technology companies preparing for their next growth round. As provider adoption, platform capabilities, and healthcare partnerships expand, the company is likely to evaluate follow-on capital, strategic healthcare investment, or acquisition interest.

9. Molecular You

Molecular You is a Canadian health technology company specializing in personalized health assessments. By analyzing over 250 blood-based biomarkers, they provide individuals and healthcare providers with comprehensive insights into health risks, enabling proactive and informed health decisions.

• Sector: Health Care
• Last known transaction date: Series A Venture, $5M, August 2025
• Why timing suggests a near-term transaction: With its $5M Series A closing in August 2025, Molecular You will be approximately 12–18 months past that raise by mid-to-late 2026. This is a timeframe consistent with when Series A health tech and diagnostics companies typically start pursuing their next growth round. As adoption grows, biomarker and data capabilities mature, and partnerships with healthcare providers scale, the company is a reasonable candidate for follow-on funding, strategic investment, or acquisition interest.

10. Verdata

Verdata is a data intelligence platform that helps point-of-sale financing companies assess and manage merchant risk. Its platform provides underwriting insights, risk notifications, and portfolio monitoring tools that help lenders identify fraud, reduce financial exposure, and improve operational efficiency.

• Sector: B2B Risk Intelligence / Fintech
• Last known transaction date: Series A Venture, $8M, August 2025
• Why timing suggests a near-term transaction: Verdata’s $8M Series A announced in August 2025 places the company roughly 12–18 months removed from its most recent financing by mid to late 2026, aligning with the typical timing for Series A fintech and data platforms preparing for their next growth round. As customer adoption, data capabilities, and financial services partnerships expand, the company is likely to evaluate follow-on capital, strategic investment, or acquisition interest.

Use Joe’s Sponsor Backed Company Intelligence to Spot Likely Exits Before the Market Does

Joe’s private company data gives you a real-time view into thousands of sponsor-backed companies, including platform acquisition dates, funding rounds, parent sponsors, add-on activity, and sector categorization.

Instead of guessing where companies are in their lifecycle, you can instantly identify which ones are approaching the typical timing windows for a sale or recap.

This dataset enables deal sourcers, investor relations teams, and allocators to anticipate transactions, build targeted outreach lists, and stay ahead of market announcements, every single day.

Filter by sector, geography, funding stage, last transaction date, or parent sponsor to build the list that matches your mandate.

To explore more companies likely to transact, request access to Joe.